Vimarsana
Biggest News Aggregation in the World

Page 37 - Amarin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Amarin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Amarin Today - Breaking & Trending Today

Amarin Corporation plc: Amarin Receives Reimbursement for VAZKEPA in Sweden - Vimarsana News

Amarin Corporation plc: Amarin Receives Reimbursement for VAZKEPA in Sweden

Marks First Health Technology Assessment (HTA) Reimbursement in Europe and Initiation of Next Phase of the Company's Growth Strategy Company Provides Progress Update on European and International Expansion

$139.43 Million in Sales Expected for Amarin Co. plc (NASDAQ:AMRN) This Quarter - Vimarsana News

$139.43 Million in Sales Expected for Amarin Co. plc (NASDAQ:AMRN) This Quarter

Brokerages expect that Amarin Co. plc (NASDAQ:AMRN – Get Rating) will report sales of $139.43 million for the current fiscal quarter, according to Zacks. Four analysts have issued estimates for Amarin’s earnings, with the lowest sales estimate coming in at $135.10 million and the highest estimate coming in at $144.30 million. Amarin posted sales of […]

Amarin (NASDAQ:AMRN) Sets New 12-Month Low at $2.79 - Vimarsana News

Amarin (NASDAQ:AMRN) Sets New 12-Month Low at $2.79

Amarin Co. plc (NASDAQ:AMRN – Get Rating) reached a new 52-week low during trading on Monday . The stock traded as low as $2.79 and last traded at $2.84, with a volume of 256364 shares traded. The stock had previously closed at $2.96. Several research firms have recently commented on AMRN. Cantor Fitzgerald reaffirmed an […]

Amarin Corporation plc: Latest analysis shows VASCEPA (icosapent ethyl) significantly lowered the risk of potentially fatal cardiovascular events in patients with prior percutaneous coronary intervention - Vimarsana News

Amarin Corporation plc: Latest analysis shows VASCEPA (icosapent ethyl) significantly lowered the risk of potentially fatal cardiovascular events in patients with prior percutaneous coronary intervention

A new post hoc sub-analysis of the landmark REDUCE-IT Study, published in the Journal of the American Heart Association (JAHA), found VASCEPA significantly reduced the risk of cardiovascular death, strokes

Bay Area motorcyclist dies in crash on Highway 101 - Vimarsana News

Bay Area motorcyclist dies in crash on Highway 101

A Petaluma motorcyclist, splitting lanes in morning traffic, died after traffic suddenly...